Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/22/2025

Magic Mouthwash Composition and Clinical Guidelines

Standard Formulation and Recommendations

  • The National Comprehensive Cancer Network (NCCN) recommends a magic mouthwash composition consisting of equal parts diphenhydramine, antacid, and viscous lidocaine for managing oral mucosa inflammation, including ICI-related mucositis 1
  • The NCCN guidelines define the three-component formulation as including antacid, typically magnesium aluminum hydroxide or Maalox 2
  • Viscous lidocaine is used as a local anesthetic in the magic mouthwash formulation 3

Clinical Context and Evidence

  • The NCCN specifically defines the magic mouthwash formulation in their 2024 immunotherapy toxicity guidelines for managing oral mucosa inflammation, including ICI-related mucositis 1
  • Earlier literature documented significant variability in magic mouthwash compositions, which may include antibiotics, antihistamines, antifungals, corticosteroids, and antacids 2, 3
  • The 2019 NCCN cancer pain guidelines suggest that bland mouth rinses using sodium bicarbonate are often recommended as an alternative to magic mouthwash 2, 3
  • Benzydamine oral rinse has supporting data for prevention and treatment of mucositis 2, 3

REFERENCES

1

nccn guidelines® insights: management of immunotherapy-related toxicities, version 2.2024. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2024

2

adult cancer pain, version 3.2019, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2019

3

adult cancer pain, version 3.2019, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2019